An Epitope on EGFR Loading Catastrophic Internalization Serve as a Novel Oncotarget for Hepatocellular Carcinoma Therapy
The precise role of Epidermal Growth Factor Receptor (EGFR) in Hepatocellular carcinoma (HCC) cells is unknown and EGFR inhibitors have not achieved positive clinical results. The rapid and drastic internalization of EGFR has been proved to successfully treat EGFR inhibitor-resistant patients in rec...
Main Authors: | Dianshuai Huang, Qingjie Fan, Zhiyi Liu, Shuqin Zhang, Wei Huang, Hongrui Li, Chongyang Liang, Fei Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-02-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/2/456 |
Similar Items
-
Elucidation of the critical epitope of an anti-EGFR monoclonal antibody EMab-134
by: Mika K. Kaneko, et al.
Published: (2018-07-01) -
Case report: EGFR fusion mutation combined with EGFR amplification responds to EGFR-TKI therapy
by: Zhulin Wang, et al.
Published: (2024-03-01) -
Upregulation of CSNK1A1 induced by ITGB5 confers to hepatocellular carcinoma resistance to sorafenib in vivo by disrupting the EPS15/EGFR complex
by: Li Gu, et al.
Published: (2023-06-01) -
Targeting Autophagy for Overcoming Resistance to Anti-EGFR Treatments
by: Yoojung Kwon, et al.
Published: (2019-09-01) -
Targeted Inhibitors of EGFR: Structure, Biology, Biomarkers, and Clinical Applications
by: Nina Shaban, et al.
Published: (2023-12-01)